ETFs Holding TTPH »    TTPH Historical Stock Prices »
TTPH News Video: Thu, Apr 7, 2016, 1:31 PM — Thursday Sector Leaders: Precious Metals, Drugs

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company, focusing on antibiotics for multidrug-resistant infections. Co. is developing its key product candidate, eravacycline, a synthetic tetracycline derivative, as an intravenous, and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multidrug-resistant infections, including multidrug-resistant Gram-negative infections. Co. is conducting a phase 3 clinical program for eravacycline called IGNITE (Investigating Gram-Negative Infections Treated with Eravacycline), which is evaluating eravacycline in complicated intra-abdominal infections and complicated urinary tract infections. Self directed investors in Tetraphase Pharmaceuticals, Inc will be interested in keeping up with all Tetraphase Pharmaceuticals, Inc news they can find, both TTPH news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on TTPH. At RediNews, we simplify this task by presenting both TTPH news releases originating from Tetraphase Pharmaceuticals, Inc itself, and TTPH news from a variety of media outlets. Visitors can browse this news online and through our TTPH RSS news feed.


TTPH News — Articles, Videos, & Press Releases

Short Interest In Tetraphase Pharmaceuticals Moves 17.8% Lower
Friday, January 11, 2019, 12:01 PM — Market News Video
First Week of August 16th Options Trading For Tetraphase Pharmaceuticals (TTPH)
Friday, January 4, 2019, 10:44 AM — Stock Options Channel
Noteworthy Friday Option Activity: FNKO, NKTR, TTPH
Friday, November 9, 2018, 3:25 PM — Stock Options Channel
SPSM's Underlying Holdings Imply 27% Gain Potential
Tuesday, October 30, 2018, 7:26 AM — ETF Channel
Sum Up The Pieces: IBB Could Be Worth $146
Thursday, September 27, 2018, 8:02 AM — ETF Channel
Short Interest Makes 12.4% Move For TTPH
Wednesday, September 26, 2018, 11:45 AM — Market News Video
Notable Monday Option Activity: AMCX, ALNY, TTPH
Monday, August 27, 2018, 3:25 PM — Stock Options Channel
Interesting TTPH Call Options For October 19th
Tuesday, August 21, 2018, 11:08 AM — Stock Options Channel
Commit To Buy Tetraphase Pharmaceuticals At $2.50, Earn 36.9% Annualized Using Options
Wednesday, August 1, 2018, 11:48 AM — Stock Options Channel
How The Parts Add Up: IBB Targets $141
Friday, July 27, 2018, 7:30 AM — ETF Channel
TTPH is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:


If you use web portal software to control the site content for your corporate portal or public internet directory and portal website, or even if you have zero experience with the notion of a dynamic stock feed for website or corporate portal sites, RediNews can be your financial tool provider of RSS headline news feeds. If you already have stock price pages, great, our RSS feed should fit right in and add another form of dynamic stock ticker specific content. Our news would go well next to intraday charts of the indexes or individual stocks, on an option chain page, or anywhere stock market data is found on your web site. You could even set up a ticker bar with a news ticker to complement a stock ticker. Depending on your level of web portal content experience, you can get really fancy with these feeds. Or even if you have no web page finance content experience yet and are just starting out integrating stock data, give our RSS feeds a try. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): .

TTPH News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.